Further Information
PLA2G4C, phospholipase A2, group IVC (cytosolic, calcium-independent), CPLA2-gamma, DKFZp586C0423, FLJ42247, FLJ44164, cytosolic phospholipase A2 gamma, phospholipase A2, cytosolic, calcium-independent, gamma, phospholipase A2, group IVC
Peptide ELISA: antibody detection limit dilution 1:128000.Western Blot:Approx 65kDa band observed in Human Brain (Hippocampus), Liver, Pancreas, and Spleen lysates (calculated MW of 62.5kDa according to NP_001152794.1). Recommended concentration: 0.03-0.1ug/ml.
- Yamashita A, Tanaka K, Kamata R, Kumazawa T, Suzuki N, Koga H, Waku K, Sugiura T, Subcellular localization and lysophospholipase/transacylation activities of human group IVC phospholipase A2 (cPLA2gamma).
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
The immunogen for this antibody is: C-NTEVIREYIFDQLR
8605
phospholipase A2 group IVC
PLA2G4C
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
Approx 65kDa
NP_003697.2, NP_001152794.1, NP_001152795.1
226693354
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Cancer,Immunology,Signal Transduction,
This antibody is expected to recognize all reported isoforms (NP_003697.2; NP_001152794.1; NP_001152795.1).
Q9UP65